Previous reports have shown that ZFNs (Li et al, 2011) and even a nuclease‐free approach (Barzel et al, 2015) are also efficient and since they insert F9 cDNA under the control of the albumin or F9 promoters, they have potential application in any case of hemophilia B regardless of the mutation. This evidence concerns the gene F9 and hemophilia B.